1. Amgen buying drug discovery biotech Nuevolution for $167M — Novartis’ asthma drug beats GSK’s Advair in trial — Lilly’s mirikizumab succeeds in phase 2 Crohn’s trial -- See more on our front page news

    Got questions about whistleblowing?: Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

VIBERZI DEAD?

Discussion in 'Allergan' started by anonymous, May 16, 2019 at 6:58 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Is anyone going to have this dog in their back in 2020?
     
  2. anonymous

    anonymous Guest

    In a related question — is anyone hearing anything about GI being restructured or realigned in Q3 or Q4? What is the timeline for the migraine pill? I hear all kinds of conflicting things.
     
  3. anonymous

    anonymous Guest



    Something is coming soon. I’ve heard bag changes first.
     
  4. anonymous

    anonymous Guest

    Are they about to cut GI reps?
     
  5. anonymous

    anonymous Guest

    never seen them cut from specialty before. If it happens things must be really bad
     
  6. anonymous

    anonymous Guest

    dead as Kelsey’s nuts!
     
  7. anonymous

    anonymous Guest

    What has anyone heard about this?
     
  8. anonymous

    anonymous Guest

    I know someone that will be interviewing out west soon for a GI rep position. Should they be worried about accepting if offered?
     
  9. anonymous

    anonymous Guest

    No because if they get laid off they will get a great payout
     
  10. anonymous

    anonymous Guest